x

Search for a clinical trial

* (*) mandatory field

A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma- BE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Epizyme, inc.
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Dr Thierry GIL
  • Clinique d'oncologie médicale
  • Institut Jules Bordet
  • Boulevard de Waterloo 121
  • 1000 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : +32 (0)2 541 31 11
  • Fax  : -
  • Website
  • Investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • General medical oncology/Algemene Medische Oncologie
  • University Hospitals Leuven - Gasthuisberg
  • Herestraat 49
  • 3000 LEUVEN
  • BELGIUM
  • More information
  • Phone  : +32 (0)16 34 69 00
  • Fax  : +32 (0)16 34 69 01
  • Website
Last update: May 2019

Part of a multinational clinical trial

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.